Drugs of abuse in urine - screening
Produkt-Code
PT-DU-SCREEN-W
Eignungsprüfungsprogramm
Matrix
Industrielle Bereich(e)
Produktformat
3 x 15ml lyophilized human urine. This is designed for participants who report using immunoassay type techniques, including POCT (point of care testing).
Akkreditierung
ISO/IEC 17043
Übersicht der Ringversuchsproben und Verteilungstermine:
Produktinformationen
Analyten-Daten
Analytenname
Bereich
Einheiten
Akkreditierung
Amfetamines screen
-
μg/L
Barbiturates Screen
-
μg/L
Benzodiazepines screen
-
μg/L
Buprenorphine and Metabolite Screen
-
μg/L
Cannabinoid Screen
-
μg/L
Cocaine and Metabolite Screen
-
μg/L
EDDP Screen
-
μg/L
LSD and Metabolite Screen
-
μg/L
Methadone Screen
-
μg/L
Opiates screen
-
μg/L
Phencyclidine Screen
-
μg/L
Propoxyphene and Metabolite Screen
-
μg/L
Screening-only membership = screening only analytes using immunoassay type techniques. For Clinical and EWDTS thresholds, please see the DAU Scheme Description.
Einzelheiten zu den vollständigen technischen Spezifikationen des Programms finden Sie in der Schemabeschreibung.